Cytosorbents Corporation - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
CTSO Nasdaq 3840 www.cytosorbents.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytosorbents Corporation

Cytosorbents Boosts Liquidity with Successful Rights Offering - Jan 14th, 2025 2:35 pm
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering - Jan 13th, 2025 12:00 pm
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai - Jan 6th, 2025 12:00 pm
CytoSorbents reported strong Q4 results, says D. Boral Capital - Jan 4th, 2025 1:15 pm
CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. - Jan 3rd, 2025 2:09 pm
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue - Jan 3rd, 2025 12:00 pm
CytoSorbents Rights Offering Begins - Dec 23rd, 2024 12:00 pm
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week - Dec 12th, 2024 12:00 pm
CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity - Dec 12th, 2024 9:28 am
CytoSorbents Announces Rights Offering - Dec 9th, 2024 12:00 pm
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference - Nov 26th, 2024 12:00 pm
CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00 - Nov 14th, 2024 8:05 am
Several Insiders Invested In Cytosorbents Flagging Positive News - Nov 12th, 2024 10:28 am
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India - Nov 11th, 2024 12:30 pm
CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ... - Nov 8th, 2024 9:03 pm
CytoSorbents: Q3 Earnings Snapshot - Nov 7th, 2024 10:58 pm
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results - Nov 7th, 2024 9:05 pm
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification - Nov 4th, 2024 12:00 pm
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review - Oct 22nd, 2024 11:00 am
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results - Oct 17th, 2024 11:00 am